2018
D. G. Birch, Bernstein, P. S., Iannacone, A., Pennesi, M. E., Lam, B. L., Heckenlively, J., Csaky, K., Hartnett, M. Elizabeth, Winthrop, K. L., Jayasundera, T., Hughbanks-Wheaton, D. K., Warner, J., Yang, P., Fish, G. Edd, Teske, M. P., Sklaver, N. L., Erker, L., Chegarnov, E., Smith, T., Wahle, A., VanVeldhuisen, P. C., McCormack, J., Lindblad, R., Bramer, S., Rose, S., Zilliox, P., Francis, P. J., and Weleber, R. G.,
“Effect of Oral Valproic Acid vs Placebo for Vision Loss in Patients With Autosomal Dominant Retinitis Pigmentosa: A Randomized Phase 2 Multicenter Placebo-Controlled Clinical Trial.”,
JAMA Ophthalmol, vol. 136, no. 8, pp. 849-856, 2018.
C. M Berin, Grishin, A., Masilamani, M., Leung, D. Y. M., Sicherer, S. H., Jones, S. M., A Burks, W., Henning, A. K., Dawson, P., Grabowska, J., Agashe, C., Davidson, W. F., Wood, R. A., and Sampson, H. A.,
“Egg-specific IgE and basophil activation but not egg-specific T-cell counts correlate with phenotypes of clinical egg allergy.”,
J Allergy Clin Immunol, vol. 142, no. 1, pp. 149-158.e8, 2018.
E. H. Payne, Gebregziabher, M., Hardin, J. W., Ramakrishnan, V., and Egede, L. E.,
“An empirical approach to determine a threshold for assessing overdispersion in Poisson and negative binomial models for count data.”,
Commun Stat Simul Comput, vol. 47, no. 6, pp. 1722-1738, 2018.
P. Nachipo, Hermann, D., Quinnan, G., Gordon, M. A., Van Voorhis, W. C., and Tam, P. - Y. Iroh,
“Evaluating the safety, tolerability, pharmacokinetics and efficacy of clofazimine in cryptosporidiosis (CRYPTOFAZ): study protocol for a randomized controlled trial.”,
Trials, vol. 19, no. 1, p. 456, 2018.
P. A. Wetzel, Lindblad, A. S., Raizada, H., James, N., Mulatya, C., Kannan, M. A., Villamar, Z., Gitchel, G. T., and Weaver, L. K.,
“Eye Tracking Results in Postconcussive Syndrome Versus Normative Participants.”,
Invest Ophthalmol Vis Sci, vol. 59, no. 10, pp. 4011-4019, 2018.
Q. Yan, Ding, Y., Liu, Y., Sun, T., Fritsche, L. G., Clemons, T., Ratnapriya, R., Klein, M. L., Cook, R. J., Liu, Y., Fan, R., Wei, L., Abecasis, G. R., Swaroop, A., Chew, E. Y., Weeks, D. E., and Chen, W.,
“Genome-wide analysis of disease progression in age-related macular degeneration.”,
Hum Mol Genet, vol. 27, no. 5, pp. 929-940, 2018.
A. E. Fombah, Goldstein, S. T., Jarrett, O. D., Jalloh, M. I., El-Khorazaty, J., Lisk, D. Radcliffe, Legardy-Williams, J., Pratt, D. A., George, P. M., Russell, J. B. W., Schrag, S. J., Dawson, P., Deen, G. F., Carr, W., Lindblad, R., James, F., Bah, M. M., Yillia, J. F., Sandy, J. D., Turay, P. E., Conteh, M. - A., Slutsker, L., Mahon, B. E., Samai, M., and Seward, J. F.,
“Health Conditions in an Adult Population in Sierra Leone: Data Reported From the Sierra Leone Trial to Introduce a Vaccine Against Ebola (STRIVE).”,
J Infect Dis, vol. 217, no. suppl_1, pp. S75-S80, 2018.
K. R. Hefner, Starr, M. J., and Curtin, J. J.,
“Heavy Marijuana Use But Not Deprivation is Associated with Increased Stressor Reactivity”,
J Abnorm Psychol, vol. 127, no. 4, pp. 348-358, 2018.
L. K. Weaver, Wilson, S. H., Lindblad, A. S., Churchill, S., Deru, K., Price, R. C., Williams, C. S., Orrison, W. W., Walker, J. M., Meehan, A., and Mirow, S.,
“Hyperbaric oxygen for post-concussive symptoms in United States military service members: a randomized clinical trial.”,
Undersea Hyperb Med, vol. 45, no. 2, pp. 129-156, 2018.
S. Chakraborty, Harro, C., DeNearing, B., Brubaker, J., Connor, S., Maier, N., Dally, L., Flores, J., A Bourgeois, L., Walker, R., and Sack, D. A.,
“Impact of lower challenge doses of enterotoxigenic Escherichia coli on clinical outcome, intestinal colonization and immune responses in adult volunteers.”,
PLoS Negl Trop Dis, vol. 12, no. 4, p. e0006442, 2018.
M. Rao, Onkar, S., Peachman, K. K., White, Y., Trinh, H. V., Jobe, O., Zhou, Y., Dawson, P., Eller, M. A., Matyas, G. R., and Alving, C. R.,
“Liposome-Encapsulated Human Immunodeficiency Virus-1 gp120 Induces Potent V1V2-Specific Antibodies in Humans.”,
J Infect Dis, vol. 218, no. 10, pp. 1541-1550, 2018.
T. F. C. Heeren, Kitka, D., Florea, D., Clemons, T. E., Chew, E. Y., Bird, A. C., Pauleikhoff, D., Issa, P. Charbel, Holz, F. G., and Peto, T.,
“LONGITUDINAL CORRELATION OF ELLIPSOID ZONE LOSS AND FUNCTIONAL LOSS IN MACULAR TELANGIECTASIA TYPE 2.”,
Retina, vol. 38 Suppl 1, pp. S20-S26, 2018.
O. D. Jarrett, Seward, J. F., Fombah, A. E., Lindblad, R., Jalloh, M. I., El-Khorazaty, J., Dawson, P., Burton, D., Zucker, J., Carr, W., Bah, M. M., Deen, G. F., George, P. M., James, F., Lisk, D. R., Pratt, D., Russell, J. B. W., Sandy, J. D., Turay, P., Hamel, M. J., Schrag, S. J., Walker, R. E., Samai, M., and Goldstein, S. T.,
“Monitoring Serious Adverse Events in the Sierra Leone Trial to Introduce a Vaccine Against Ebola.”,
J Infect Dis, vol. 217, no. suppl_1, pp. S24-S32, 2018.
S. P. Broglio, Kontos, A. P., Levin, H., Schneider, K., Wilde, E. A., Cantu, R. C., Feddermann-Demont, N., Fuller, G. W., Gagnon, I., Gioia, G. A., Giza, C., Griesbach, G. S., Leddy, J. J., Lipton, M. L., Mayer, A. R., McAllister, T. W., McCrea, M., McKenzie, L. B., Putukian, M., Signoretti, S., Suskauer, S. J., Tamburro, R., Turner, M., Yeates, K. O., Zemek, R., Ala'i, S., Esterlitz, J., Gay, K., Bellgowan, P. S. F., and Joseph, K.,
“National Institute of Neurological Disorders and Stroke and Department of Defense Sport-Related Concussion Common Data Elements Version 1.0 Recommendations.”,
J Neurotrauma, vol. 35, no. 23, pp. 2776-2783, 2018.
M. W. Lawlor, Iannaccone, S. T., Mathews, K., Muntoni, F., Alai-Hansen, S., Odenkirchen, J. C., and Feldman, R. S.,
“NINDS Common Data Elements for Congenital Muscular Dystrophy Clinical Research: A National Institute for Neurological Disorders and Stroke Project.”,
J Neuromuscul Dis, vol. 5, no. 1, pp. 75-84, 2018.
R. J. Carter, Senesi, R. G. B., Dawson, P., Gassama, I., Kargbo, S. A. S., Petrie, C. R., Rogers, M. Hashim, Samai, M., and Luman, E. T.,
“Participant Retention in a Randomized Clinical Trial in an Outbreak Setting: Lessons From the Sierra Leone Trial to Introduce a Vaccine Against Ebola (STRIVE).”,
J Infect Dis, vol. 217, no. suppl_1, pp. S65-S74, 2018.
R. W. Frenck, Baqar, S., Alexander, W., Dickey, M., McNeal, M., El-Khorazaty, J., Baughman, H., Hoeper, A., Barnoy, S., Suvarnapunya, A. E., Kaminski, R. W., and Venkatesan, M. M.,
“A Phase I trial to evaluate the safety and immunogenicity of WRSs2 and WRSs3; two live oral candidate vaccines against Shigella sonnei.”,
Vaccine, vol. 36, no. 32 Pt B, pp. 4880-4889, 2018.
P. A. Carpenter, Logan, B. R., Lee, S. J., Weisdorf, D. J., Johnston, L., Costa, L. J., Kitko, C. L., Bolaños-Meade, J., Sarantopoulos, S., Alousi, A. M., Abhyankar, S., Waller, E. K., Mendizabal, A., Zhu, J., O'Brien, K. A., Lazaryan, A., Wu, J., Nemecek, E. R., Pavletic, S. Z., Cutler, C. S., Horowitz, M. M., and Arora, M.,
“A phase II/III randomized, multicenter trial of prednisone/sirolimus prednisone/ sirolimus/calcineurin inhibitor for the treatment of chronic graft--host disease: BMT CTN 0801.”,
Haematologica, vol. 103, no. 11, pp. 1915-1924, 2018.
M. Chehade, Jones, S. M., Pesek, R. D., A Burks, W., Vickery, B. P., Wood, R. A., Leung, D. Y. M., Furuta, G. T., Fleischer, D. M., Henning, A. K., Dawson, P., Lindblad, R. W., Sicherer, S. H., J Abonia, P., Sherrill, J. D., Sampson, H. A., and Rothenberg, M. E.,
“Phenotypic Characterization of Eosinophilic Esophagitis in a Large Multicenter Patient Population from the Consortium for Food Allergy Research.”,
J Allergy Clin Immunol Pract, vol. 6, no. 5, pp. 1534-1544.e5, 2018.
D. F. Hoft, Xia, M., Zhang, G. L., Blazevic, A., Tennant, J., Kaplan, C., Matuschak, G., Dube, T. J., Hill, H., Schlesinger, L. S., Andersen, P. L., and Brusic, V.,
“PO and ID BCG vaccination in humans induce distinct mucosal and systemic immune responses and CD4 T cell transcriptomal molecular signatures.”,
Mucosal Immunol, vol. 11, no. 2, pp. 486-495, 2018.
L. C. Ku, Hornik, C. P., Beechinor, R. J., Chamberlain, J. M., Guptill, J. T., Harper, B., Capparelli, E. V., Martz, K., Anand, R., Cohen-Wolkowiez, M., and Gonzalez, D.,
“Population Pharmacokinetics and Exploratory Exposure-Response Relationships of Diazepam in Children Treated for Status Epilepticus.”,
CPT Pharmacometrics Syst Pharmacol, vol. 7, no. 11, pp. 718-727, 2018.
U. E. K. Wolf-Schnurrbusch, Leung, I., Sallo, F. B., Clemons, T. E., Chew, E. Y., Bird, A. C., and Peto, T.,
“Potential Effects of Hormone Therapy in Type 2 Idiopathic Macular Telangiectasia.”,
Ophthalmic Res, vol. 60, no. 1, pp. 38-42, 2018.
K. Modjarrad, Lin, L., George, S. L., Stephenson, K. E., Eckels, K. H., De La Barrera, R. A., Jarman, R. G., Sondergaard, E., Tennant, J., Ansel, J. L., Mills, K., Koren, M., Robb, M. L., Barrett, J., Thompson, J., Kosel, A. E., Dawson, P., Hale, A., C Tan, S., Walsh, S. R., Meyer, K. E., Brien, J., Crowell, T. A., Blazevic, A., Mosby, K., Larocca, R. A., Abbink, P., Boyd, M., Bricault, C. A., Seaman, M. S., Basil, A., Walsh, M., Tonwe, V., Hoft, D. F., Thomas, S. J., Barouch, D. H., and Michael, N. L.,
“Preliminary aggregate safety and immunogenicity results from three trials of a purified inactivated Zika virus vaccine candidate: phase 1, randomised, double-blind, placebo-controlled clinical trials.”,
Lancet, vol. 391, no. 10120, pp. 563-571, 2018.
L. A. Jackson, Sahly, H. M. El, George, S., Winokur, P., Edwards, K., Brady, R. C., Rouphael, N., Keitel, W. A., Mulligan, M. J., Burton, R. L., Nakamura, A., Ferreria, J., and Nahm, M. H.,
“Randomized clinical trial of a single versus a double dose of 13-valent pneumococcal conjugate vaccine in adults 55 through 74 years of age previously vaccinated with 23-valent pneumococcal polysaccharide vaccine.”,
Vaccine, vol. 36, no. 5, pp. 606-614, 2018.
]